Effects of Modafinil on Brain Function in Patients With Schizophrenia
Status:
Completed
Trial end date:
2017-06-16
Target enrollment:
Participant gender:
Summary
This study will evaluate whether modafinil improves cognition in patients with schizophrenia
and healthy volunteers. Modafinil is a drug that has been FDA approved for day-time
sleepiness and allegedly increase the amount of the neurotransmitter dopamine in the frontal
cortex of the brain
...